Navigation Links
Web will work wonders for the faint hearted
Date:2/14/2008

A new device could put the beat back into weak hearts - and free patients from a lifetime of anti-rejection drugs.

Current implanted heart assist devices function by sucking blood from the ventricles and then expelling it into downstream vessels. Whilst these have been successful in prolonging the lives of heart patients, they come into contact with the blood stream and hence require life-long drug therapy to suppress the immune system and prevent blood clotting. In addition, many of these devices use high speed turbines to produce the pumping force, and this has been proven to cause damage to cells within the blood increasing the chance of clots forming.

The ingenious device being developed by engineers at the University of Leeds provides a less invasive alternative. The team has developed a specially-woven web made from biocompatible material which will not be rejected by the body.

The webbing wraps around the heart and therefore does not come into contact with the blood stream. Inbuilt sensors recognise when the heart wants to beat and trigger a series of miniature motors which cause the web to contract increasing the internal pressure and assisting the heart to pump the blood around the body.

The team consists of Drs Peter Walker (who devised the original concept) and Martin Levesley from the Universitys School of Mechanical Engineering, cardiac consultants Kevin Watterson and Osama Jaber from Leeds General Infirmary and engineering PhD student David Keeling. The research has been funded by Leeds-based medical charity Heart Research UK.

Its a really simple concept that works in the same way as when you squeeze a plastic bottle, forcing the liquid inside to rise, says PhD student David Keeling who has built a special rig to test the device.

The device is currently at prototype stage with team using a computer simulated model of the human blood flow circuit coupled to Davids mechanical rig. The rig replicates the motion of the heart within the simulation under different conditions, and allows the team to test their web device. The group is currently testing their latest prototype, aiming to refine design and assist strategies. Says David: Weve been looking at finding the optimum timing to trigger and also length of the compressive squeeze.

Once the mechanics have been perfected, the team intends to simulate the effects of different heart diseases to gauge the potential success of the device.

Potential uses for the device are huge. As well as offering support to people suffering from heart and valve problems, the device could also be a bridging aid to patients as they wait for transplants, providing them with a better quality of life. Says David: Recent research has found that with some heart diseases, supporting the heart for a short period with an assistive device reduces the work-load on the heart and allows it to rest and recover. Our device also allows for a controlled relaxation of the heart muscle after contraction, which means that its being supported throughout the whole heartbeat process. Its the same as when you pull a muscle in any other part of your body, rest can often be the best therapy.


'/>"/>

Contact: Jo Kelly
jokelly@campuspr.co.uk
44-113-258-9880
University of Leeds
Source:Eurekalert  

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Web will work wonders for the faint hearted
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: